David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$397M |
| 2 |
YHOO
Yahoo Inc
YHOO
|
+$342M |
| 3 |
Bank of America
BAC
|
+$322M |
| 4 |
Citigroup
C
|
+$260M |
| 5 |
Booking.com
BKNG
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$637M |
| 2 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$397M |
| 3 |
Gilead Sciences
GILD
|
+$358M |
| 4 |
Phillips 66
PSX
|
+$330M |
| 5 |
Apple
AAPL
|
+$320M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.78% |
| 2 | Technology | 11.11% |
| 3 | Financials | 10% |
| 4 | Consumer Discretionary | 8.83% |
| 5 | Communication Services | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Gerdau
GGB
$8.75B
| $2.41M | ﹤0.01% |
1,705,147
+1,097,653
| +181% | +$976K |
|
1727
Griffon
GFF
$4.57B
| $2.41M | ﹤0.01% |
155,845
+11,150
| +8% | +$169K |
|
1728
Credit Acceptance
CACC
$6.16B
| $2.4M | ﹤0.01% |
13,215
-2,202
| -14% | -$420K |
|
1729
PUT
NetApp
NTAP
$38B
| $2.4M | ﹤0.01% |
87,900
+14,100
| +19% | +$342K |
|
1730
PUT
United Airlines
UAL
$37.3B
| $2.39M | ﹤0.01% |
40,000
-46,700
| -54% | -$2.48M |
|
|
ZOES
1731
DELISTED
Zoe's Kitchen, Inc.
ZOES
| $2.39M | ﹤0.01% |
61,387
-22,114
| -26% | -$696K |
|
1732
Compañía de Cervecerías Unidas
CCU
$2.29B
| $2.39M | ﹤0.01% |
106,499
+82,441
| +343% | +$1.69M |
|
1733
Zillow
Z
$7.86B
| $2.39M | ﹤0.01% |
100,684
+27,238
| +37% | +$569K |
|
1734
PUT
Archer Daniels Midland
ADM
$38.6B
| $2.39M | ﹤0.01% |
65,700
-63,600
| -49% | -$2.21M |
|
1735
PUT
JD.com
JD
$38.9B
| $2.38M | ﹤0.01% |
90,000
-82,400
| -48% | -$2.16M |
|
|
QIHU
1736
PUT
DELISTED
QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS
QIHU
| $2.38M | ﹤0.01% |
31,500
-100,000
| -76% | -$7.23M |
|
1737
PUT
Meritage Homes
MTH
$4.71B
| $2.37M | ﹤0.01% |
130,200
| – | – |
|
1738
CALL
Expedia Group
EXPE
$40B
| $2.37M | ﹤0.01% |
22,000
-51,200
| -70% | -$5.46M |
|
|
NTUS
1739
DELISTED
Natus Medical Inc
NTUS
| $2.37M | ﹤0.01% |
61,684
+43,477
| +239% | +$1.62M |
|
|
KYNB
1740
Kyntra Bio
KYNB
$32.8M
| $2.37M | ﹤0.01% |
4,451
-5,365
| -55% | -$2.67M |
|
1741
Ennis
EBF
$543M
| $2.37M | ﹤0.01% |
120,974
+64,043
| +112% | +$1.25M |
|
|
AD
1742
Array Digital Infrastructure
AD
$3.08B
| $2.37M | ﹤0.01% |
51,753
-8,496
| -14% | -$331K |
|
1743
CVR Energy
CVI
$4.02B
| $2.36M | ﹤0.01% |
90,458
+57,942
| +178% | +$1.69M |
|
|
ESIO
1744
DELISTED
Electro Scientific Industries
ESIO
| $2.36M | ﹤0.01% |
329,513
+168,361
| +104% | +$1.09M |
|
|
GAP
1745
PUT
The Gap Inc
GAP
$7.61B
| $2.35M | ﹤0.01% |
80,000
-61,500
| -43% | -$1.62M |
|
|
BRKL
1746
DELISTED
Brookline Bancorp
BRKL
| $2.35M | ﹤0.01% |
213,581
-60,526
| -22% | -$652K |
|
1747
CALL
Intercontinental Exchange
ICE
$90.9B
| $2.35M | ﹤0.01% |
50,000
-50,000
| -50% | -$2.43M |
|
1748
CALL
KB Home
KBH
$3.44B
| $2.35M | ﹤0.01% |
164,600
| – | – |
|
1749
Reinsurance Group of America
RGA
$16.1B
| $2.35M | ﹤0.01% |
24,380
-34,138
| -58% | -$3.01M |
|
1750
Dentsply Sirona
XRAY
$2.18B
| $2.34M | ﹤0.01% |
+37,986
| New | +$2.24M |
|
Similar funds
David Shaw's Q1 2016 Portfolio in Review
As of Q1 2016, David Shaw held 4,137 positions worth $55.7B, down 17% from $67.2B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.
David Shaw withdrew a net $9.72B in Q1 2016, closing 773 positions and reducing 1,495 holdings. Its most notable exit was PRECISION CASTPARTS CORP, an estimated $637M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, up from 13% a quarter earlier, followed by Technology and Financials.
Against the trend, David Shaw opened a new position in EQT Corp worth $47.6M.
- David Shaw's largest Q1 2016 buy was EQT Corp: 1,300,361 shares worth $47.6M.
- David Shaw added most to Allergan plc in Q1 2016, an estimated $397M increase.
- David Shaw's biggest Q1 2016 reduction was Gilead Sciences, cutting an estimated $358M.
- David Shaw fully exited PRECISION CASTPARTS CORP in Q1 2016, selling an estimated $637M.
- David Shaw's ten largest holdings make up 9.5% of its $55.7B portfolio in Q1 2016.
- David Shaw opened 382 new positions and closed 773 in Q1 2016.
- David Shaw's portfolio value fell 17% quarter-over-quarter to $55.7B.
Based on D.E. Shaw & Co's 13F filing for Q1 2016, filed 16 May 2016.